Guidelines

in Chronic Venous Insufficiency and Varicose Veins

Applied

Type

Modification

Confidence

90%

Created

Apr 19, 2026

Evidence

1 source

Rationale

The existing farah 2021 citation for the SVS/AVF/AVLS guideline recommendation on endovenous ablation preference has been superseded by the 2025 revised guideline (PMID 40154779). Per the stale guideline replacement instructions, farah 2021 is replaced with SVS for this claim rather than appending both citations. The heading is updated to note the 2025 revision. All other section content, structure, and citations are preserved unchanged.

Evidence

SVS. A comparison and AGREE II analysis of the revised Society for Vascular Surgery/American Venous Forum/American Vein and Lymphatic Society and European Society for Vascular Surgery clinical practice guidelines in the management of varicose veins. J Vasc Surg Venous Lymphat Disord. 2025. PMID: 40154779. DOI: 10.1016/j.jvsv.2025.102238.
Verified source
PubMedDOI

Content Changes

<!-- type: guidelines -->

* **Society for Vascular Surgery (SVS)/American Venous Forum (AVF)/American Vein and Lymphatic Society (AVLS) Guidelines (2022):**[@farah2021](2022, updated 2025):**[@svs2025]
  + Endovenous ablation preferred over surgery for great saphenous vein (GSV) and small saphenous vein (SSV) reflux.
* **ESVS Guidelines (2015):**[@esvs2015]
  + Compression in all Clinical-Etiology-Anatomy-Pathophysiology (CEAP) ≥C3.
  + Endovenous therapy first-line for symptomatic varicose veins.
  + Stenting indicated for significant iliac obstruction with symptoms.
* **NICE Guidelines (UK, 2013):**
  + Offer endothermal ablation as first-line, foam sclerotherapy if unsuitable.
Go to section in textbookDispute / Submit evidenceAll updates